Purpose Differential methylation of both HOXA10 and catechol-O-methyltransferase (COMT) has been reported in different endometrium disorders, and the two genes are linked through the estrogen pathway. The current study investigates the DNA methylation of HOXA10 and COMT in ectopic and eutopic endometrial tissues and its correlation with and the occurrence of endometriosis in women from Xinjiang province in China. Methods In the current study, 120 patients with endometriosis were recruited from our hospital between January 2011 and June 2014. The DNA methylation sites of HOXA10 and COMT were detected using a DNA methylation array. The methylation levels of specific sites were compared between ectopic and eutopic endometrial tissues via pyrosequencing. Results Five differentially expressed CpGs were localized in the promoter region of the COMT gene and expressed significantly higher in the ectopic endometrium than the eutopic endometrium (P < 0.001). Two out of the five differentially expressed CpGs in the HOXA10 gene located in the promoter region were both significantly lower (nearly half) in the ectopic endometrium than the eutopic endometrium (P < 0.001). Conclusions To summarize, significant differential methylation of HOXA10 and COMT promoter regions was found between the ectopic and eutopic endometrial tissues. This is the first study investigating the methylation of HOXA10 and COMT genes and their linkage to endometriosis in Chinese patients.
Introduction
Endometriosis affects up to 15% women almost exclusively in the reproductive age, causing infertility and development of Fei Ji and Xinhua Yang contributed equally to this work. adhesions due to the extra-uterine growth of endometriumlike tissue [1, 2] . The molecular cause of endometriosis is multifactorial, including disease occurrence and severity influenced by genetic, environmental, and lifestyle factors [3] . The existing theories on the cellular origin of endometriosis include retrograde menstruation, coelomic metaplasia, embryonic cell rest theory, and stem cell theory [4, 5] . Among these, Sampson's retrograde menstruation model, retrograde flow of sloughed endometrial cells/debris via the fallopian tubes into the pelvic cavity during menstruation, remains most widely accepted [6] . Although endometriosis is a benign disease, increasing pieces of evidence support the hypothesis that it represents the initial stages of neoplastic processes. The common characteristics shared by endometriosis and cancer include the ability to evade apoptosis, the adult stem cell-like dysregulation, neovascularization, progressive course, implantation at distant sites, the creation of a microenvironment that renders its course independent, and mobilization of the immune system [7] . Aberrant DNA methylation has been identified as a vital mechanism in tumorigenesis and multiple other diseases [8, 9] . A recent study analyzed the genome-wide DNA methylation in patients with endometriosis and identified 42,248 differentially methylated CpGs in the endometriosis cells as compared to the healthy cells [10] . The homeobox gene (HOX) clusters were some of the maximum differentially methylated families of genes [10] . HOX genes are dynamically expressed in the endometrium, where they are necessary for endometrial growth, differentiation, and implantation. HOXA10 gene hyper-methylation has recently been demonstrated to silence the gene expression and accounts for the decreased expression in the women with endometriosis [11, 12] . Catechol-O-methyltransferase (COMT) can inactivate catechol estrogens, metabolites of estradiol (E2) that can bind estrogen receptor, and these catechols are involved in the pathogenesis of endometriosis [13] . There are increased levels of membrane-bound COMT protein in ovarian endometrial tissues [13] , but the relevance of COMT polymorphisms to endometriosis remains in debate [14, 15] , and the methylation status of COMT in endometriosis remains to be revealed. Because endometriosis is an estrogen-dependent disease, and COMT and HOXA10 are upstream and downstream of estrogen regulation, respectively [16, 17] , they can be critical components in the pathogenesis of endometriosis as well as its potential progression to cancer. We present a simplified schematic of their possible roles in the pathogenesis of endometriosis in Fig. 1 .
Hitherto, most studies encompassing the epigenetic causes of endometriosis or endometrial cancers are conducted in the Western world. Little has been investigated in China. The current study recruited patients who were long-term residents of Xinjiang province. We aimed to investigate the DNA methylation of HOXA10 and COMT in ectopic and eutopic endometrial tissues and its correlation with and the occurrence of endometriosis.
Materials and methods

Patients
The present study recruited patients between January 2011 and June 2014 at the Department of Gynecology, The First Affiliated Hospital of Xinjiang Medical University from the southern, northern, and eastern Xinjiang province. The patients who fulfilled the following criteria were included: (1) provided full consent; (2) were of childbearing age (between 20 and 48 years old); (3) were scheduled to receive laparoscopic or open abdominal surgery for treating endometriosis as primary indication; (4) did not have abnormal menstrual cycle history; (5) did not receive hormonal treatment during the past 3 months; and (6) residing for more than 5 years in Xinjiang province with no inter-racial marriage in the past three generations. Patients excluded were those who (1) had gestational diseases and impaired uterus and, thus, could not allow the sample collection of eutopic endometrial tissues; (2) had cardiovascular, neural, lung, liver, or kidney diseases; and (3) had hypertension, diabetes, cancer, or chronic infectious diseases. The study cohort consisted of 60 endometriosis patients and 120 endometrial tissues (ectopic and eutopic, 60 of each). Information about the patients' demographics, tissues, and disease stage (according to the revised American Fertility 
DNA extraction
Both ectopic and eutopic endometrial tissues were collected from the participants during the surgery. One gram of each tissue sample was immediately stored in liquid nitrogen and then at −80°C until further usage. The DNA from the endometrium tissues was extracted using the DNA extraction kit (QIAGEN, CA, USA) following the manufacturer's protocol.
DNA methylation array
Bisulfite conversion was performed after DNA extraction. DNA methylation array was then conducted using the Infinium Human Methylation 450 BeadChip array (Illumina, CA, USA) based on the manufacturer's protocol. Briefly, the genome DNA was first treated with sodium bisulfite and then used for the PCR amplification of HOXA10 and COMT. PCR primers (Primer-G) are listed in Table 1 . Subsequently, the PCR products were treated with shrimp alkaline phosphatase (SAP) and the resulting fragments analyzed to detect the differentially methylated CpG sites (selection criteria: false discovery rate (FDR) <0.05 and beta change ≥0.2). The differentially methylated sites were further confirmed with HOXA10 or COMT gene sequence (NCBI) and those located in the promoter region were identified.
Methylation-specific PCR
To assess the methylation status of the HOXA10 and COMT promoter regions, we employed methylation-specific PCR using primers for differentially methylated regions. PCR primers and conditions are listed in Tables 1 and 2 , respectively. Each methylation-specific PCR reaction utilized 25 ng of sodium bisulfite to convert the DNA (Zymo EZ DNA Methylation kit, ZYMO Research, CA, USA) from the template of either ectopic and eutopic endometrial tissues. The female genomic DNA that was either fully methylated and bisulfite converted or fully demethylated and bisulite converted was used as a control.
The PCR products were resolved on 3% agarose gel and visualized with ethidium bromide under ultraviolet (UV) light. If the primers targeting the methylated sequence resulted in successful PCR amplification, while the primers targeting the unmethylated sequence failed to result in PCR amplification, this suggested that homozygotic methylation was present in the 5′ CpG of the promoter. If the specific primers targeting both the methylated and unmethylated sequences both resulted in PCR amplification, this suggested that heterozygotic methylation had occurred in the promoter region. If the primers targeting the methylated sequence failed to initiate PCR amplification, this indicated the absence of methylation in the promoter region. Pyrosequencing A pyrosequencing assay was used to analyze the methylation levels of each CpG site in the promoter region of HOXA10 and COMT through the PyroMark Q96 ID system (QIAGEN). A forward primer with the M13 sequence at the 5′ site of one of the previous methylation-specific PCR primers (Primer M) was designed for either the HOXA10 or COMT promoter region with Assay Design Software 1.0 (Biotage, MA, USA) ( Table 1 ). The PCR reaction was carried out using Primer M and the amplicons of the previous methylation-specific PCR reactions that showed homozygotic or heterozygotic methylation of the promoter region. After confirming the anticipated amplifications using DNA electrophoresis, the PCR amplification of the pyrosequencing template was carried out using the biotinylated M13 primer and PCR products of the previous reaction. The biotinylated PCR products were then immobilized onto the streptavidin beads, and the pyrosequencing reaction was conducted by following the system protocol. Pyrograms were produced in the CpG methylation analysis software PyroMark CpG SW 1.0.11 (QIAGEN), and sequencing results, including sequence and methylation level, were compared between the ectopic and eutopic endometrial tissues based on the methylation sites of HOXA10 and COMT, respectively.
Statistical analysis
Data were analyzed using the R software version 2.15.2 (https://www.r-project.org/). Results are presented as mean ± standard deviation (SD). Paired Student's t test was used to compare the results between ectopic and eutopic endometrium samples. Two-tailed P < 0.05 was considered statistically significant.
Results
Subjects
In the present study, we enrolled 60 endometriosis patients from south, north, and east of Xinjiang province between January 2011 and June 2014 at the Department of Gynecology, The First Affiliated Hospital of Xinjiang Medical University. These 60 patients constituted of 30 from the Han population and the other 30 from Uyghur. The mean ages of these patients were 41 and 42 years (Han and Uyghur, respectively; range from 20 to 48 years). Both the ectopic and eutopic endometrial tissue samples were obtained from each patient, as well as another clinical information, such as disease stage of the patients as summarized in Table 3 .
Differential methylation sites of HOXA10 and COMT
Based on the DNA methylation array, five differentially methylated CpG sites were detected each in the COMT and HOXA10 genes (Table 3 ). All the five CpG sites in COMT were located in the promoter region, while only two out of the five CpGs in the HOXA10 gene were located in the promoter region (*CpG sites in Table 4 ).
Methylation levels of promoter region CpGs
Based on the pyrosequencing results, the methylation levels of the five differentially methylated CpG sites in COMT promoter region were significantly higher in the ectopic endometrium than the eutopic tissue (Fig. 2 , a Differential methylation sites in the promoter region P < 0.001). Four out of the five sites (except CG18773129) showed nearly double methylation level in the ectopic endometrium than the eutopic endometrium. Contrastingly, the methylation levels of the two differentially methylated CpG sites in HOXA10 promoter region were significantly lower (nearly half) in the ectopic endometrium than the eutopic tissue ( Fig. 3 , P < 0.001).
Discussion
To our knowledge, this is the first study investigating the methylation of HOXA10 and COMT genes and their linkage to endometriosis in Chinese patients. We found that differential methylation of the COMT gene is entirely localized in the promoter region and is strongly upregulated in the ectopic endometrium. In contrast, the differential methylation of HOXA10 is not exclusive to the promoter region and the differential methylation of its promoter regions is downregulated in the ectopic endometrium.
Our results are consistent with the previous findings and provide accurate information on the differential methylation of the promoter region of the two genes. Recent animal and human studies have reported HOXA10 hyper-methylation, a putative mechanism by which HOXA10 levels could be decreased in endometriosis [11, 12, 18] . In the animal endometriosis models, Hoxa10/HOXA10 was hyper-methylated at the 5′ promoter region and its expression was downregulated in the eutopic endometrium [11, 12] . In humans, three CpG-rich fragments in the HOXA10 gene were identified. Moreover, HOXA10 was hyper-methylated on all the fragments in the endometrium of women with endometriosis as compared to the controls [18] . Similarly, we have found hyper-methylation of HOXA10 promoter in the eutopic endometrium vs. ectopic endometrium, suggesting the downregulation of the gene. However, through the DNA methylation array, we identified only two differentially methylated CpG sites in the HOXA10 promoter region. This may occur as the current study compared the ectopic and eutopic tissues in endometriosis patients while the previous study by Wu et al. (2005) compared endometrial tissues between endometriosis patients and those who did not have endometriosis [19] . Therefore, the current study provides information on tissue-specific methylation pattern of the HOXA10 promoter region.
An important and novel finding of this study is the differential methylation of COMT in ectopic endometriosis. Hitherto, DNA methylation of COMT and its correlation with endometriosis had not been reported. However, it is understood that COMT is likely to play a role in endometriosis [20] . COMT inactivates the estradiol metabolites, 2-hydroxy and 4-hydroxy catechols, which have been implicated in the pathogenesis of endometriosis [20] . The CpG methylation density in the membrane-bound COMT promoter has been found to be significantly higher in the endometrial cancer tissues than in the adjacent normal tissues [21] . Our finding of hyper-methylation of COMT in the ectopic endometrium vs. eutopic endometrial tissues is the first report in endometriosis patients, which suggests a critical role of the COMT gene in regulating estrogen-induced malignancies, possibly progressed from endometriosis.
However, the present study has the following limitations. Although the between-tissue group comparison can be satisfied with the current sample size, in order to understand the differential DNA methylation of HOXA10 and COMT by patient disease stage or between the two ethnicities will require a large sample size for future studies. We also did not undertake detailed analysis of the methylation levels of the three other differentially methylated CpG islands that were not located in the promoter region in HOXA10; this should be investigated fully later.
Conclusions
To summarize, differential methylation in the promoter region of HOXA10 and COMT genes was found between the ectopic and eutopic endometrial tissues of patients with endometriosis from the Xinjiang province of China. The current study was a pilot experiment to explore the epigenetic causes of endometriosis in Chinese patients. Our findings indicate that further studies utilizing animal models may provide deeper insight into the molecular mechanisms involving HOXA10 and COMT genes in the development of endometriosis. The racial and disease stage-specific analysis may also further elucidate whether the methylation levels of the two genes are correlated with these factors.
